|
Market Closed -
Australian S.E.
08:58:05 13/11/2026 +04
|
5-day change | 1st Jan Change | ||
| 0.2400 AUD | -4.00% |
|
-9.43% | -40.00% |
| 10-05 | Alterity Therapeutics Limited Presents New Analyses of Ath434 Phase 2 Data in Multiple System Atrophy | CI |
| 09-16 | Lake Street Initiates Alterity Therapeutics at Buy With $10 Price Target | MT |
Company Valuation: Alterity Therapeutics Limited
Data adjusted to current consolidation scope
| Fiscal Period: June | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 21.56 | 11.37 | 14 | 59.84 | 86.52 | 39 | - | - |
| Change | - | -47.27% | 23.14% | 327.48% | 44.59% | -54.92% | - | - |
| Enterprise Value (EV) 1 | 21.56 | 11.37 | 9.172 | 38.2 | 59.75 | 29.05 | 2.07 | 33.29 |
| Change | - | -47.27% | -19.31% | 316.5% | 56.4% | -51.38% | -92.88% | 1,508.8% |
| P/E | - | - | - | - | -5.17x | -2.44x | -0.23x | -3.13x |
| PBR | - | - | - | - | - | - | - | - |
| PEG | - | - | - | - | - | 0.31x | -0x | 0x |
| Capitalization / Revenue | 6.11x | 4.45x | 4.81x | 11.3x | 22.6x | 30.9x | 17.1x | 13.4x |
| EV / Revenue | 6.11x | 4.45x | 3.15x | 7.24x | 15.6x | 23x | 0.91x | 11.5x |
| EV / EBITDA | - | - | -0.71x | -4.68x | -3.33x | -1.2x | -0.09x | -1.65x |
| EV / EBIT | -2.07x | -1.22x | -0.71x | -4.87x | -3.33x | -1.09x | -0.07x | -1.13x |
| EV / FCF | -2.53x | - | -1.07x | -5.11x | -3.7x | -1.36x | -0.1x | -1.85x |
| FCF Yield | -39.6% | - | -93.4% | -19.6% | -27% | -73.8% | -1,019% | -54.1% |
| Dividend per Share 3 | - | - | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - | - | - |
| EPS 3 | - | - | - | - | -0.1112 | -0.1025 | -1.1 | -0.08 |
| Distribution rate | - | - | - | - | - | - | - | - |
| Net sales 1 | 3.528 | 2.554 | 2.909 | 5.278 | 3.832 | 1.264 | 2.279 | 2.906 |
| EBITDA 1 | - | - | -12.95 | -8.155 | -17.94 | -24.15 | -23.12 | -20.13 |
| EBIT 1 | -10.42 | -9.321 | -12.97 | -7.839 | -17.94 | -26.75 | -29.58 | -29.45 |
| Net income 1 | -8.843 | -8.966 | -12.97 | -7.927 | -16.83 | -27.2 | -29.15 | -27.47 |
| Net Debt 1 | - | - | -4.826 | -21.64 | -26.77 | -9.953 | -36.93 | -5.708 |
| Reference price 3 | 0.6500 | 0.3500 | 0.2000 | 0.5000 | 0.5750 | 0.2500 | 0.2500 | 0.2500 |
| Nbr of stocks (in thousands) | 48,137 | 48,798 | 104,902 | 182,547 | 217,509 | 229,101 | - | - |
| Announcement Date | 31/08/22 | 31/08/23 | 29/08/24 | 28/08/25 | 28/08/26 | - | - | - |
1AUD in Million2USD in Million3AUD
Estimates
P/E, Detailed evolution
| P/E (N) | EV / Sales (N) | EV / EBITDA (N) | Dividend Yield (N) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -2.68x | 26.28x | -1.38x | - | 43.17M | |
| 17.64x | 6.77x | 12.98x | 1.69% | 67.53B | |
| 32.85x | 8.79x | 29.04x | 0.07% | 60.74B | |
| 38.46x | 6.84x | 20.46x | 0.85% | 55.66B | |
| 46.76x | 6.33x | 30.27x | -.--% | 47.97B | |
| 35.83x | 3.38x | 14.58x | -.--% | 45.24B | |
| -21.57x | 57.33x | -23.69x | -.--% | 39.08B | |
| 35.06x | 8.67x | 22.58x | 0.37% | 35.34B | |
| 41.53x | 8.15x | 27.06x | -.--% | 33.45B | |
| -73.68x | 13.96x | -75.03x | -.--% | 26.49B | |
| Average | 15.02x | 14.65x | 5.69x | 0.33% | 41B | |
| Weighted average by Cap. | 21.93x | 12.19x | 11.37x | 0.43% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
- Stock Market
- Stocks
- ATH Stock
- Valuation Alterity Therapeutics Limited
Select your edition
All financial news and data tailored to specific country editions
